Recent Financings of Private Companies (09/11)
This article was originally published in Start Up
Executive Summary
Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.
You may also be interested in...
Takeda Test Drives EMA’s Parallel Review Route For EU And Non-EU Markets
A new evaluation route that the European Medicines Agency launched last year came at the right time for Takeda’s dengue vaccine candidate.
Science-Based THC Limits ‘Urgently Needed’ For EU To Compete In Global CBD Market
“We urgently need the adoption of an EU wide regulation on sound scientific THC limits in food,” insisted EIHA president and Hempro International CEO Daniel Kruse at the association's 18th annual conference, “Hemp for Europe: Emerging opportunities for the Green Recovery.”
Germany's EVP Enters Spain's Supplements Market With Korott
German private-label specialist EVP Group is poised to enter the Spanish market with the acquisition of local supplements and cosmetics player Korott.